List of bibliographic references indexed by safety
Number of relevant bibliographic references: 9.
| Ident. | Authors (with country if any) | Title |
|---|
| 000021 (2019) |
Micha Loebermann [Allemagne] ; Carlos Fritzsche [Allemagne] ; Hilte Geerdes-Fenge [Allemagne] ; Esther Heijnen [Pays-Bas] ; Daniel Kirby [États-Unis] ; Emil C. Reisinger [Allemagne] | A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults. |
| 000040 (2018) |
Roman Prymula [République tchèque] ; Dorothee Kieninger [Allemagne] ; Emmanuel Feroldi [France] ; Emilia Jordanov [États-Unis] ; Siham B'Chir [France] ; Xavier Dacosta [États-Unis] | Immunogenicity and Safety of Primary and Booster Vaccinations of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine in Healthy Infants and Toddlers in Germany and the Czech Republic. |
| 000092 (2016) |
Jakob P. Cramer [Allemagne] ; Katrin Dubischar [Autriche] ; Susanne Eder [Autriche] ; Gerd D. Burchard [Allemagne] ; Tomas Jelinek [Allemagne] ; Bernd Jilma [Autriche] ; Herwig Kollaritsch [Autriche] ; Emil Reisinger [Allemagne] ; Kerstin Westritschnig [Autriche] | Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO® in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study. |
| 000205 (2013) |
Ulrich Zimmermann [Allemagne] ; Gaëtan Gavazzi ; Patrick Richard ; Cécile Eymin ; Benoît Soubeyrand ; Martine Baudin | Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax) administered concomitantly versus non-concomitantly with an influenza vaccine (Vaxigrip) to adults aged ≥60 years: an open-label, randomised trial. |
| 000229 (2012) |
Mathieu Peeters [Belgique] ; Stefan Regner ; Tejaswini Vaman ; Jeanne-Marie Devaster ; Lars Rombo | Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: data from two multicentre randomised trials. |
| 000267 (2011) |
S. Wicker [Allemagne] ; H F Rabenau ; H. Ackermann ; G A Poland ; G. Marckmann | [Does patient safety justify mandatory vaccinations?]. |
| 000292 (2011) |
J. Garcia-Sicilia [Espagne] ; P. Gillard ; A. Carmona ; J C Tejedor ; J. Aristegui ; J M Merino ; U. Behre ; A. Caplanusi ; T. Vaman ; I. Dieussaert | Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents. |
| 000394 (2009) |
Ned Stafford | Only 12% of Germans say they will have H1N1 vaccine after row blows up over safety of adjuvants. |
| 000441 (2007) |
| [Opinion of the experts--possible general and individual uses. High purity--additional safety aspect]. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeAllemagneV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "safety"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i \
-Sk "safety" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeAllemagneV3
|flux= Main
|étape= Exploration
|type= indexItem
|index= Title.i
|clé= safety
}}
| This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 11:47:10 2020. Site generation: Sat Sep 26 09:55:33 2020 |  |
